AB InBev ADRs slide ~3% as traders brace for near-term earnings, targets cut
Anheuser-Busch InBev’s U.S.-listed ADRs (BUD) fell about 3.4% to roughly $73 as investors positioned ahead of the company’s near-term earnings release. The stock has also faced recent analyst price-target cuts, including a TD Cowen reduction to $70 from $85 in late April.
1. What’s happening in the stock
Anheuser-Busch InBev SA/NV’s ADRs (NYSE: BUD) were down about 3.39% in Monday trading (May 4, 2026), with the shares around $73.00. The pullback appears tied to positioning ahead of the company’s imminent earnings event, with traders often reducing exposure or hedging into the print when expectations are tight and volatility is elevated. (lines.com)
2. The key catalyst: earnings setup and risk reduction
The near-term earnings window is in focus, and the stock’s drop fits a typical “risk-off into results” pattern—particularly for globally exposed consumer names where currency, input costs, and demand trends can shift guidance sensitivity. Even without a single headline, the proximity of the earnings catalyst can drive selling pressure, especially after a run-up or when the tape turns defensive. (lines.com)
3. Additional overhang: recent price-target cuts
BUD has also been dealing with a softer analyst tone in recent weeks. TD Cowen cut its price target to $70 from $85 (while keeping its rating), a move that can reinforce investor caution and encourage profit-taking or de-risking into the next catalyst. (streetinsider.com)
4. What to watch next
Near-term direction is likely to hinge on whether AB InBev delivers clean volume and margin trends and whether it reiterates or improves its outlook. Investors will also watch for any commentary on regional demand, pricing power, and leverage/debt trajectory, since any disappointment on these items can quickly translate into multiple compression for a large-cap consumer staple ADR.